Month: June 2023

Press release, Helsinki, 7 June 2023 at 10 AM (EEST) Nexstim Receives an NBS 5+ System Order from a New US Customer Nexstim Plc (NXTMH:HEX) (“Nexstim” or “Company”) announces having received an NBS 5+ system order in the United States from a new customer in North Carolina. The NBS 5+ system combines the capabilities of Nexstim’s NBS (Navigated Brain Stimulation) and NBT® (Navigated Brain Therapy) systems. The NBS system is FDA cleared for pre-surgical mapping of the speech and motor cortices of the brain and the NBT® system for marketing and commercial distribution for the treatment of major depressive disorder (MDD). Both systems are based on Nexstim’s unique navigated transcranial magnetic stimulation (nTMS) technology that allows for accurate and personalized targeting of the stimulation to the brain. Mikko Karvinen,...

  QazCode will provide world-class digital products and solutions to operators, businesses and public sector partners Amsterdam, 7 June – VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces that Beeline Kazakhstan, its operator in Kazakhstan, has launched a software company QazCode to boost development of new digital products and services. The 700-strong QazCode will be among the largest software development companies in Kazakhstan and will include 350 developers with expertise across software development, big data analytics, cybersecurity and artificial intelligence (AI). QazCode will build digital products and services for both local Kazakh and international clients, including other VEON digital operators. The formation of QazCode is part...

STMicroelectronics and Sanan Optoelectronics to advance Silicon Carbide ecosystem in ChinaSTMicroelectronics and Sanan Optoelectronics to create a Joint Venture (‘JV’) for high-volume 200mm SiC device manufacturing JV will support rising demand for STMicroelectronics SiC devices in China for car electrification and industrial power and energy applications Sanan to build separately a 200mm SiC substrate manufacturing facility to fulfill the JV’s needsGeneva (Switzerland) and Xiamen (China), June 7, 2023 – STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, and Sanan Optoelectronics (SHA.600703), a market leader in compound semiconductors in China, engaged in LEDs, SiC, Optical Communications, RF, Filters and GaN products, today announced that they have signed...

GENOMIQUE | THÉRAPIES CELLULAIRES ET GÉNIQUES | BIOPRODUCTION                  Genomic Vision présente sa nouvelle orientation stratégiqueFaire progresser l’analyse génomique dans la bioproduction, les thérapies cellulaires et géniques et la découverte de médicaments Mettre en priorité l’innovation pour le contrôle qualité tout au long du cycle de la bioproduction Lancement d’un logiciel d’analyse basé sur l’Intelligence Artificielle (IA) et développement d’une plateforme technologique de nouvelle génération pour accélérer et simplifier l’analyse génomique à haut débitBagneux (France) – Genomic Vision (FR0011799907 – GV, la « Société »), une société de biotechnologie cotée sur Euronext développant des produits et des services pour la caractérisation précise des séquences d’ADN, présente sa nouvelle orientation stratégique. Forte...

Press release  Nokia Threat Intelligence Report finds malicious IoT botnet activity has sharply increasedNumber of IoT devices (bots) engaged in botnet-driven DDoS attacks rose from around 200,000 a year ago to approximately 1 million devices7 June 2023 Espoo, Finland – The latest Nokia Threat Intelligence Report released today has found that IoT botnet DDoS (Distributed Denial of Service) traffic, originating from a large number of insecure IoT devices with the aim of disrupting telecom network services for millions of users, increased fivefold over the past year, following Russia’s invasion of Ukraine and stemming from the growing increase in profit-driven hacking collectives operated by cybercriminals. This sharp increase, also supplemented by the increased use of IoT devices by consumers around the world, was first noticed at...

Novel antibiotics were developed by Spexis in close collaboration with Professor Oliver Zerbe’s group at the University of Zurich with substantial funding by Innosuisse and CARB-X ALLSCHWIL, Switzerland, June 06, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced the publication of preclinical results from the company’s novel class of macrocyclic, peptidomimetic antibiotics developed in collaboration with the University of Zurich, demonstrating potent in vitro and in vivo antimicrobial activity against multidrug resistant (MDR) and extensively drug resistant (XDR) Enterobacteriaceae. The manuscript, titled “Peptidomimetic Antibiotics Disrupt the Lipopolysaccharide Transport Bridge of Drug-Resistant Enterobacteriaceae,” is available online...

Hamilton, Bermuda June 7, 2023Avance Gas Holding Ltd (“Avance Gas” or “the Company”) (OSE: AGAS) has today entered into a newbuilding contract with CIMC for the construction of two mid-sized LPG/ammonia carriers with dual fuel engines that can run on LPG as fuel in addition to compliant fuel oil. The ships will have a cargo capacity of 40,000 cubic meters and scheduled delivery is during the fourth quarter 2025 and the first quarter of 2026. As the ships will also be equipped with shaft generators this will further improve operation and maintenance cost while improving the environmental profile. In addition to transporting traditional LPG cargoes, the vessels will also be fully able to carry ammonia cargoes. The seaborn ammonia trade is expected to grow significantly in the coming years due to the numerous blue and green ammonia projects....

NAARDEN, The Netherlands and MIAMI, June 06, 2023 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol, for whom existing therapies are not sufficiently effective or well-tolerated, today announced the pricing of the previously announced underwritten public offering of 13,857,415 shares of the Company’s ordinary shares, with a nominal value of €0.12 per share (“Ordinary Shares,” such offering, the “Offering”) by certain of the Company’s existing shareholders, including affiliates of Forbion Capital Partners (collectively, the “Selling Shareholders”), at a public offering price of $11.50 per...

BRISBANE, Calif., June 06, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced the pricing of its underwritten public offering of 11,538,462 shares of its common stock at a public offering price of $13.00 per share. All shares of common stock are being offered by Day One. The gross proceeds to Day One from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $150.0 million. In addition, Day One has granted the underwriters a 30-day option to purchase up to an additional 1,730,769 shares of its common stock at the public offering price, less underwriting discounts...